[1]
“A randomized, parallel, open-label clinical study comparing the effectiveness and safety of apremilast with methotrexate in individuals with moderate to severe palm plantar psoriasis”., Ind-Am. J Life. Sci. Biotech., vol. 18, no. 3, pp. 68–79, Jul. 2021, Accessed: Mar. 07, 2026. [Online]. Available: https://iajlb.org/index.php/iajlb/article/view/84